Send us Fan Mail

When the appetite suppression from a GLP-1 fades, hunger may feel different.

And for some people, food noise comes back with it.

In Episode 3 of the After GLP-1 series, Sharon, Nurse Practitioner and host of the Stable Health Podcast, introduces Satiety Nutrition—a practical approach to eating that helps support fullness and hunger regulation during the transition after GLP-1 therapy.

Instead of trying to recreate medication-level appetite suppression through extreme restriction, this episode focuses on building meals that naturally provide greater staying power.

Sharon breaks down three foundational tools: protein, fiber, and hydration—and explains how each can play a role in satiety, meal structure, and managing the return of hunger.

You'll learn why protein deserves a place at the center of meals, how fiber adds volume and supports fullness, why hydration can become surprisingly important after GLP-1 treatment, and how combining these strategies can make meals more satisfying without returning to restrictive dieting.

Most importantly, this episode reframes hunger.

Feeling hungry again doesn't mean you've failed.

Your body is responding to a changing biological environment—and the goal is to build a nutrition strategy that can work with those signals rather than spending every day fighting them.

Episode 1 introduced the metabolic handoff.

Episode 2 established muscle as the anchor.

Now Episode 3 addresses the next piece of the transition:

How do you eat when hunger comes back?

The answer isn't starvation.

It's satiety.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

What becomes your metabolic anchor when the medication changes?

Muscle.

In Episode 2 of the After GLP-1 series, Sharon, Nurse Practitioner and host of the Stable Health Podcast, explores The Muscle Anchor—why preserving and building lean mass should become a major priority during the transition beyond GLP-1 therapy.

Weight loss can include both fat and lean mass. And because muscle is metabolically active tissue, losing too much of it can affect strength, function, body composition, and daily energy expenditure.

That's where resistance training comes in.

Sharon explains how strength training provides the body with a powerful metabolic stimulus, helping preserve lean mass as weight changes and supporting the foundation needed for long-term weight management.

This episode reframes the post-GLP-1 transition from simply trying to "keep the weight off" to intentionally building a body that is stronger and better equipped for what comes next.

You'll learn why the scale can't tell you whether you're preserving muscle, how lean mass relates to basal metabolic rate, why protein and resistance training work together, and why strength—not simply a lower body weight—deserves a place among your long-term measures of success.

The medication may have helped create the opportunity.

Now it's time to build the anchor.

Muscle isn't just something you want to preserve during weight loss. It's something you want to carry forward.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

What actually happens to your body when a GLP-1 medication stops?

For many people, the answer isn't simply, "My appetite comes back."

There is a biological transition happening.

In Episode 1 of the After GLP-1 series, Sharon, Nurse Practitioner and host of the Stable Health Podcast, explores the biological and statistical realities of discontinuing GLP-1 therapy—and why maintaining weight loss afterward can be difficult without a structured plan.

This episode introduces the concept of the hormonal rebound: the return of biological signals that influence hunger, appetite, satiety, and energy balance once medication support is removed.

Sharon also examines what clinical studies have shown about weight regain following GLP-1 discontinuation and why regain should not automatically be interpreted as a lack of discipline or a failure of treatment.

Instead, the conversation introduces a different approach: the metabolic handoff.

Rather than thinking of the last injection as the end of treatment, the metabolic handoff treats it as a transition—one that requires intentional strategies to support appetite regulation, lean mass, nutrition, physical activity, and long-term metabolic health.

Because stopping the medication doesn't mean the biology that contributed to weight gain disappeared.

And maintaining progress requires more than willpower.

It requires a plan for what comes next.

The medication may stop. The strategy shouldn't.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

GLP-1 medications can help you eat less—but eating less creates a new challenge:

How do you make sure you're still eating enough of what your body actually needs?

In this episode of the Stable Health Podcast GLP-1 Series, Sharon explores the protein-first lifestyle and why protein becomes especially important during GLP-1 treatment.

As appetite decreases and weight comes down, the goal isn't simply to lose weight. It's to lose weight while protecting lean muscle, maintaining strength, supporting adequate nutrition, and building eating habits that can last beyond the medication.

You'll learn what "protein first" actually means, why muscle preservation matters for metabolism and healthy aging, and practical ways to prioritize protein when large meals suddenly feel impossible.

Sharon also discusses how to build meals around quality protein sources, spread protein throughout the day, pair it with fiber and nutrient-dense foods, and recognize when reduced appetite may be turning into inadequate nutrition.

This isn't about forcing down massive amounts of protein or following another restrictive diet.

It's about making the food you can eat count.

Because on a GLP-1, eating less is often easy.

Eating well still requires intention.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

The scale is only part of the story.

When you're taking a GLP-1 medication, some of the most important changes are happening where you can't see them—in your labs, your metabolism, and your long-term health risk.

In Episode 3 of the Stable Health Podcast GLP-1 Series, Sharon explores the laboratory markers and clinical data that help providers measure success beyond pounds lost.

You'll learn which labs are commonly monitored before and during treatment, including blood sugar, A1C, insulin resistance markers, cholesterol levels, liver function, kidney function, and nutritional status.

Sharon also discusses why weight loss alone isn't the goal. The real objective is metabolic optimization: improving cardiovascular risk, reducing inflammation, supporting muscle preservation, and creating sustainable improvements in overall health.

Whether you've lost 5 pounds or 50, understanding what your labs reveal can help you see the bigger picture of what GLP-1 therapy may be doing inside your body.

Because true success isn't just about a lower number on the scale.

It's about building a healthier metabolic future.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

GLP-1 medications don't work by "melting fat."

They work by changing the biological signals that regulate hunger, fullness, digestion, and blood sugar.

In Episode 2 of the Stable Health Podcast GLP-1 Series, Sharon takes a deeper look at how these medications work inside the body and what patients should expect during treatment.

You'll learn how GLP-1 receptor agonists affect the brain's appetite centers, slow stomach emptying, improve insulin response, and help reduce food noise—the constant mental chatter around eating that many people struggle with every day.

Sharon also discusses the most common side effects, why they happen, how dose titration works, and practical strategies for managing nausea, constipation, dehydration, and reduced appetite while maintaining adequate nutrition.

Whether you're currently taking a GLP-1 medication or considering one, understanding the mechanism behind the medication can help you navigate treatment with greater confidence and realistic expectations.

Because successful weight management isn't just about eating less.

It's about working with your biology instead of constantly fighting it.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

GLP-1 medications are everywhere in the headlines.

They're changing the conversation around weight loss, diabetes, and metabolic health—but behind the buzz is a fascinating story about how the body regulates hunger, fullness, blood sugar, and energy balance.

In this episode of the Stable Health Podcast, Sharon explains the science behind GLP-1 medications in plain language.

You'll learn what GLP-1 actually is, how these medications work inside the body, why they help people feel fuller with less food, and how they affect blood sugar regulation, insulin response, digestion, and appetite signaling.

Sharon also explores why obesity is increasingly understood as a complex metabolic condition rather than simply a matter of willpower, and why GLP-1 medications have become one of the most significant advances in metabolic medicine in decades.

Whether you're taking a GLP-1 medication, considering one, or simply curious about the science behind the headlines, this episode offers a clear, evidence-based explanation of what's really happening inside the body.

Because understanding your metabolism is the first step toward improving it.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

When most people hear the word osteoporosis, they picture an older woman.

That's exactly why so many men miss the warning signs.

In this episode of the Stable Health Podcast, Sharon explores the often-overlooked reality of osteoporosis in men—why it's underdiagnosed, undertreated, and frequently discovered only after a serious fracture has already occurred.

You'll learn why men remain at significant risk despite having larger bones, which medical conditions and medications accelerate bone loss, and why hip fractures can be especially dangerous for older men.

Sharon also breaks down the risk factors men should know about, including low testosterone, long-term steroid use, smoking, heavy alcohol use, family history, and certain chronic medical conditions.

Most importantly, this episode explains what men can do now to protect their bones through screening, strength training, nutrition, and lifestyle changes.

Because osteoporosis doesn't care whether you're a man or a woman.

And the best time to protect your bones is before the first fracture happens.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

Most women know menopause can bring hot flashes, sleep disruption, and mood changes.

What many don't realize is that one of the most important changes happening during this time is completely silent.

In the years surrounding menopause, women can lose a significant amount of bone density—often without any symptoms at all.

In this episode of the Stable Health Podcast, Sharon explains why menopause is such a critical period for bone health, how declining estrogen accelerates bone loss, and what steps women can take to protect their bones before fractures occur.

You'll learn who may need earlier bone density screening, why strength training becomes increasingly important during midlife, how calcium and vitamin D support skeletal health, and where hormone therapy fits into the conversation.

Sharon also discusses why women who experience early menopause—whether naturally, surgically, or due to medical treatment—deserve special attention when it comes to bone protection and long-term health planning.

Because osteoporosis doesn't begin with a fracture.

It begins years earlier, during a window when prevention has the greatest impact.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.

Send us Fan Mail

For years, many Medicare beneficiaries have been unable to access GLP-1 medications for weight management because of one major barrier: cost.

That may now be changing.

In this episode of the Stable Health Podcast, Sharon explains the new Medicare GLP-1 Bridge—a federal program that gives eligible Medicare Part D beneficiaries access to certain GLP-1 medications for a fixed $50 monthly copay.

You'll learn who may qualify, which clinical criteria matter, why prior authorization is still required, and how the program differs from regular Medicare Part D coverage.

Sharon also explains why this development matters beyond weight loss. For many older adults, excess weight is closely connected to mobility limitations, cardiovascular risk, sleep apnea, insulin resistance, fatty liver disease, and the ability to remain active and independent.

This is not automatic coverage for everyone, and the medication still needs to be medically appropriate. But for eligible beneficiaries, the Medicare GLP-1 Bridge may represent a meaningful new pathway to treatment that was previously unaffordable.

If you have Medicare Part D and have been wondering whether a GLP-1 medication may now be within reach, this episode will help you understand the program and prepare for a more informed conversation with your healthcare provider.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.